Hoechst merger hits setback
PLANS to merge Hoechst and Rhone-Poulenc, the German and French pharmaceutical giants, were put on hold at the last minute yesterday pending the approval of Hoechst's largest shareholder, the Kuwait Petroleum Corporation (KPC). Rhone-Poulenc said its board had approved plans to accelerate a merger but later cancelled a scheduled press conference to explain the deal. The merger, which would create the world's biggest drug maker, would require both companies to sell most of their chemicals businesses during a downturn in the chemicals cycle.
In February KPC, which owns 24.5 per cent of Hoechst, said the merger did not serve its interests on the terms then suggested.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies